Kidney Disease News and Research

RSS

Single-pill therapy achieves better long-term blood pressure control

Antihypertensive medications combined into a single pill lowered blood pressure more effectively than typical treatment with multiple pills for patients in Jamaica and Colombia, a study co-led by UT Southwestern Medical Center researchers shows.

8 Nov 2026

ZEUS trial challenges assumptions about targeting inflammation in heart disease

Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought.

8 Nov 2026

A simple salt swap could prevent nearly 3 million deaths a year, researchers estimate

A global modelling study covering 193 countries and territories estimated that replacing regular salt with a potassium-enriched substitute containing 25% potassium chloride could prevent 2.96 million deaths, 10.17 million new cardiovascular and chronic kidney disease cases, and 69.43 million disability-adjusted life years annually. Although the researchers projected an increased risk of hyperkalemia-related deaths among people with impaired kidney function, the estimated cardiovascular benefits substantially outweighed these potential harms.

5 Nov 2026

Dialysis may not be the default treatment for older kidney patients

Dialysis should not necessarily be regarded as the default option for older people with kidney failure, the first randomized study of its kind in the world, led by the University of Bristol, has found.

4 Nov 2026

A study of 27,000 adults links bean products and soy compounds to lower kidney disease odds

A cross-sectional study of 27,003 adults in Northeast China found that higher consumption of processed bean products and soy isoflavones was associated with lower odds of chronic kidney disease, while plain bean intake showed no significant association. The relationship with soy isoflavones was stronger in women, although the observational findings cannot establish whether these foods protect against kidney disease.

4 Nov 2026

Switching to potassium-enriched salt could prevent millions of global deaths

Researchers from The George Institute for Global Health assessed the health benefits of switching the salt supply to potassium-enriched salt across 193 countries.

4 Nov 2026

A three-drug diabetes pill outperformed dual therapy

Clinical trial results indicate that a fixed-dose combination of dapagliflozin, glimepiride, and metformin offers superior glycemic control in diabetes therapy.

4 Nov 2026

A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission

In a randomized clinical trial involving 96 adults with early-onset type 2 diabetes and obesity, a 24-week program combining a low-energy diet with supervised exercise achieved diabetes remission in 54% of participants, compared with 4% receiving usual care. The intervention also reduced body fat, largely preserved muscle mass, and improved strength and body-mass-adjusted fitness, although the additional benefits attributable specifically to exercise remain uncertain.

3 Nov 2026

New study links cannabis use to increased cardiovascular risk

Cannabis use, including marijuana, appears to be linked with increased cardiovascular risk, especially for stroke, making it an important consideration for heart disease and stroke prevention and counseling, according to independent, new preliminary research to be presented at the American Heart Association's Scientific Sessions 2026.

2 Nov 2026

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026

UDE students develop wearable sensor patch for noninvasive health tracking

Having blood drawn, sending samples to a lab, waiting for results: Monitoring metabolic health often involves time-consuming tests.

29 Oct 2026

Michigan Medicine study reveals how diabetes drug reduces stroke risk

For millions living with type 2 diabetes, heart disease remains one of the greatest threats to their health.

28 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

High-scoring endocrinologists are more likely to prescribe key diabetes drugs

Endocrinologists who scored highest on the American Board of Internal Medicine's Longitudinal Knowledge Assessment (LKA®) were more likely to prescribe a key diabetes drug class following a treatment guidelines update compared to doctors with lower scores.

27 Oct 2026

Mount Sinai wins $4 million NIH grant to improve prediction of postoperative acute kidney injury

Researchers at the Icahn School of Medicine at Mount Sinai have received a five-year National Institutes of Health grant of approximately $4 million to improve prediction and prevention of postoperative acute kidney injury (AKI), a potentially serious complication after surgery.

27 Oct 2026

Geriatric chronic kidney disease patients benefit from SGLT2 inhibition

New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2026 October 22–25.

26 Oct 2026

Kidney Week 2026 features late-breaking clinical trials in kidney care

The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25.

24 Oct 2026

Nephrologist shortages linked to higher kidney disease mortality along US-Mexico borde

New research indicates that US-Mexico border counties experience disproportionately elevated rates of death from chronic kidney disease (CKD), alongside reduced availability of nephrologists. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

Common kidney tests underestimate chronic kidney disease in cancer patients

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

Potassium binder helps dialysis patients manage dietary restrictions

Dietary potassium restriction is important for managing hyperkalemia, or high blood potassium levels, in individuals on maintenance hemodialysis, but it imposes a substantial day-to-day burden.

22 Oct 2026